JP2023516010A5 - - Google Patents

Info

Publication number
JP2023516010A5
JP2023516010A5 JP2022551783A JP2022551783A JP2023516010A5 JP 2023516010 A5 JP2023516010 A5 JP 2023516010A5 JP 2022551783 A JP2022551783 A JP 2022551783A JP 2022551783 A JP2022551783 A JP 2022551783A JP 2023516010 A5 JP2023516010 A5 JP 2023516010A5
Authority
JP
Japan
Prior art keywords
payload
protein
nucleic acid
pharmaceutical composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022551783A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023516010A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2021/050236 external-priority patent/WO2021168577A1/en
Publication of JP2023516010A publication Critical patent/JP2023516010A/ja
Publication of JP2023516010A5 publication Critical patent/JP2023516010A5/ja
Pending legal-status Critical Current

Links

JP2022551783A 2020-02-25 2021-02-25 遺伝子送達システム Pending JP2023516010A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202062981464P 2020-02-25 2020-02-25
US62/981,464 2020-02-25
US202063079841P 2020-09-17 2020-09-17
US63/079,841 2020-09-17
PCT/CA2021/050236 WO2021168577A1 (en) 2020-02-25 2021-02-25 Gene delivery system

Publications (2)

Publication Number Publication Date
JP2023516010A JP2023516010A (ja) 2023-04-17
JP2023516010A5 true JP2023516010A5 (cg-RX-API-DMAC10.html) 2024-03-05

Family

ID=77490538

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022551783A Pending JP2023516010A (ja) 2020-02-25 2021-02-25 遺伝子送達システム

Country Status (5)

Country Link
US (1) US20250242012A1 (cg-RX-API-DMAC10.html)
EP (1) EP4110401A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023516010A (cg-RX-API-DMAC10.html)
CA (1) CA3168968A1 (cg-RX-API-DMAC10.html)
WO (1) WO2021168577A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4117697A1 (en) * 2020-03-13 2023-01-18 PrecisionBiotics Group Limited Bifidobacterium longum
JP2024511941A (ja) * 2021-03-11 2024-03-18 テンザ、インク. 酵母における異種タンパク質の分泌を指示するための合成シグナルペプチド
CA3177045A1 (en) * 2021-03-15 2022-09-22 Beth Israel Deaconess Medical Center, Inc. Compositions and methods for treating coronavirus infection

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994006903A1 (en) * 1992-09-22 1994-03-31 Dnx Biotherapeutics, Inc. Delivery of proteins by intermembrane transfer for preaccommodation of xenogeneic organ transplants and other purposes
AU2511901A (en) * 1999-12-23 2001-07-09 Universite De Geneve Basolateral sorting signal and inhibitors thereof
US7713737B2 (en) * 2004-10-04 2010-05-11 Trinity Biosystems, Inc. Methods and compositions for needleless delivery of macromolecules
PT1996238T (pt) * 2006-02-28 2016-07-11 Vaxart Inc Vetores adenovíricos quiméricos e arncd como agonista de tlr3
BRPI0712073B8 (pt) * 2006-05-17 2021-05-25 Hoffmann La Roche ácido nucléico para produção de um polipeptídio ou proteína heteróloga
WO2010121207A1 (en) * 2009-04-17 2010-10-21 Burnham Institute For Medical Research Methods and compositions related to the interaction of t-cadherin and adiponectin
EP2985345B1 (en) * 2013-04-10 2018-03-14 National University Corporation Hamamatsu University School of Medicine Method for inhibiting proliferation of high lix1l-expressing tumor cell, and tumor cell proliferation-inhibiting peptide
EP3105254B1 (en) * 2014-02-14 2019-11-20 Symvivo Corporation Hybrid proteins and uses thereof
KR20170121291A (ko) * 2015-03-02 2017-11-01 신로직 인코포레이티드 감소된 창자 염증 및/또는 강화된 창자 점막 장벽으로부터 이익을 얻는 질병을 치료하기 위해 공학처리된 박테리아
US10695385B2 (en) * 2015-06-25 2020-06-30 National University Corporation Kobe University Oral cancer vaccine
EP3560513A4 (en) * 2016-12-26 2020-10-14 National University Corporation Kobe University ANTICANCER THERAPY USING A COMBINATION OF AN ORAL TUMOR VACCINE AND AN IMMUNOSUPPRESSION INHIBITOR
AU2018301667A1 (en) * 2017-07-12 2020-02-06 Fundação D. Anna De Sommer Champalimaud E Dr. Carlos Montez Champalimaud Foundation Methods and systems for conditionally regulating gene expression

Similar Documents

Publication Publication Date Title
CA3030451C (en) Compositions and methods for alphavirus vaccination
Wang et al. Oral immunization with a Lactobacillus casei‐based anti‐porcine epidemic diarrhoea virus (PEDV) vaccine expressing microfold cell‐targeting peptide Co1 fused with the COE antigen of PEDV
JP2017122120A5 (cg-RX-API-DMAC10.html)
JP2020078318A5 (cg-RX-API-DMAC10.html)
CN106232138A (zh) 新型结核分枝杆菌疫苗
CN1972710B (zh) 包含噬菌体纳米颗粒的方法和组合物
CN106434728B (zh) 表达高致病性禽流感h5n1血凝素ha蛋白的重组枯草芽孢杆菌
CN118086162A (zh) 一种黏附增强型工程益生菌及其应用
US20220226459A1 (en) Dosage regimens for vaccines
Kajikawa et al. Adjuvant effects for oral immunization provided by recombinant Lactobacillus casei secreting biologically active murine interleukin-1β
US9925259B2 (en) Immunogenic polypeptide surface layer-expressing bifidobacterium
CN116157149A (zh) 改造的牛分枝杆菌疫苗
CN101455846B (zh) 脱乙酰壳聚糖递送系统组装的结核基因疫苗及其制备和应用
Yeh et al. Activated human nasal epithelial cells modulate specific antibody response against bacterial or viral antigens
US10226529B2 (en) Adjuvant for mucosal vaccine
JP2024523329A5 (cg-RX-API-DMAC10.html)
Lee et al. Dendritic cell-mediated mechanisms triggered by LT-IIa-B5, a mucosal adjuvant derived from a type II heat-labile enterotoxin of Escherichia coli
CN110214028A (zh) 联合使用口服肿瘤疫苗和免疫抑制阻滞剂的癌症治疗
RU2745626C1 (ru) Способ создания живой вакцины против коронавирусной инфекции COVID-19 на основе пробиотического штамма Enterococcus faecium L3 и живая вакцина Enterococcus faecium L3-pentF-covid-19
EP4396208A1 (en) Tuberculosis vaccines
Desheva et al. Development of live vaccine based on the Enterococcus faecium L3 vector for prevention influenza infections
KR20220113674A (ko) 셀리악 병의 치료
CN116806146A (zh) 呼吸系统疾病相关病症的治疗和预防
RU2782529C1 (ru) Способ создания живого штамма энтерококка L3-SARS на основе биологически активного штамма Е. faecium L3
JP2020176221A (ja) メンブレンヴェシクル